Physician profile
Amanda Smith
NPI 1245380419
$1,047.25
in general payments reported to CMS, 2019-2025
23 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $337 · 2023: $112 · 2024: $285 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.28 | 2021-2025 | |
| Astellas Pharma US INC | $105.84 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $99.54 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.93 | 2022-2025 | |
| Novo Nordisk INC | $74.61 | 2025 | Ozempic |
| Shield Therapeutics INC | $50.94 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $47.78 | 2024 | |
| Baxter Healthcare | $44.07 | 2024 | Perclot |
| Exeltis, USA INC. | $43.81 | 2021-2022 | |
| Exact Sciences Corporation | $34.18 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $24.35 | 2022 | |
| Organon LLC | $23.77 | 2025 | Nexplanon |
| Millicent US INC | $23.52 | 2023 | Intrarosa |
| Abbott Laboratories | $23.29 | 2021 | |
| Gynesonics, INC. | $20.72 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $19.34 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mylan Pharmaceuticals INC. | $19.14 | 2022 | |
| Pfizer INC. | $19.11 | 2022 | |
| Bausch Health US, LLC | $18.28 | 2024 | Aplenzin, Wellbutrin |
| Therapeuticsmd, INC. | $16.55 | 2022 | |
| Ibsa Pharma INC. | $16.24 | 2023 | Tirosint, Licart |
| Scynexis, INC. | $14.55 | 2022 | |
| Aspira Women'S Health INC | $12.41 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.